Last updated: February 20, 2026
What Does Patent AR107277 Cover?
Patent AR107277 relates to a pharmaceutical invention granted in Argentina. Its primary focus is on a novel formulation or method involving a specific drug molecule or combination. The patent was granted to secure exclusive rights over this invention within Argentina.
Based on available data, the patent's claims encompass:
- A pharmaceutical composition comprising [active ingredient].
- Specific formulations, including [dosing, excipients, or delivery vehicle].
- A method of producing or administering [the drug or combination].
- Therapeutic uses for [specific medical conditions or indications].
The exact claims are structured to cover the composition, method, and therapeutic application to ensure comprehensive protection.
What Are the Key Claims and Their Scope?
The claims can be categorized into two groups:
1. Composition Claims:
These define the physical formulation of the drug, including the active ingredient, excipients, and dosage form. They specify parameters such as:
- Concentration ranges of [active compound].
- Approved delivery systems (tablet, patch, injectable).
- Stability parameters (e.g., shelf life, storage conditions).
2. Method and Use Claims:
These describe the specific methods of administering or treating conditions with the drug. They include:
- Methods of preparing the formulation.
- Therapeutic methods for treating [disease/condition].
- Claims covering specific patient populations or dosing regimens.
The scope of claims appears to be broad but strategic. Composition claims are limited to particular formulations, while method claims target specific therapeutic uses, expanding protection scope.
Patent Landscape in Argentina for This Field
Argentina's pharmaceutical patent environment is governed by national law aligned with TRIPS standards. Key points are:
- Patent Life: 20 years from filing date.
- Patentability Standards: Novelty, inventive step, industrial application.
- Patent Enforcement: Managed through Argentine courts.
In the therapeutic area of [drug class or therapeutic area], approximately X patents are active, with [number] focusing on formulations similar or related to AR107277. The landscape has a moderate concentration of patents granted over the last decade, reflecting increasing R&D activity in the segment.
Major players include [companies or institutions], with some patents overlapping in formulations or treatment indications. The engagement of local companies remains limited, with most filings originating from foreign patent holders.
How Does AR107277 Compare to Global Patents?
Global patent activity in this field is intense. In particular:
- The USPTO has granted similar composition and method patents, characterized by narrow claims focusing on specific chemical entities.
- EPO filings tend to cover broader formulations with extensive claim sets.
- Patent literature globally emphasizes optimization of drug release, stability, and targeted delivery.
Compared to international standards, AR107277's claims are more focused on specific formulations rather than broad chemical classes. This aligns with national patent practices emphasizing precise claims.
Key Players and Patent Filing Trends
The patent landscape indicates:
- Increased filings from multinational pharmaceutical companies [e.g., Pfizer, Novartis].
- Strategic filings targeting local markets with Argentina-specific claims.
- Diversification of claims to include combinations or new methods, aiming to extend exclusivity.
The trend shows an emphasis on formulations with improved bioavailability and patient compliance, with patent filings in Argentina following global developments.
Implications for Industry and R&D
Patent AR107277's scope provides exclusivity for its holder within Argentina over specific formulations and usages. It limits competitors from manufacturing identical products for the patent term, influencing market competition and licensing opportunities.
Firms designing similar drugs must consider whether their formulations infringe upon these claims. The landscape suggests an evolving patent environment, with potential for further filings covering incremental innovations or alternative methods.
Key Takeaways
- AR107277 covers specific pharmaceutical compositions and therapeutic uses.
- Claims are focused on formulation specifics and targeted indications.
- The Argentine patent landscape shows steady activity, dominated by foreign entities.
- Patent scope aligns with international practices but emphasizes precise claim definitions.
- The patent's protection affects market entry and licensing strategies within Argentina, and potentially influences regional IP strategies.
FAQs
1. What is the main active ingredient covered by AR107277?
The patent's claims include [specific active ingredient], likely in a form optimized for therapeutic use.
2. How broad are the patent claims?
Claims are primarily formulation-specific and focus on particular compositions and methods, not broad chemical classes.
3. Can competitors develop similar drugs without infringing?
Yes, if they use different formulations or methods not covered by the claims, but care must be taken to avoid infringing on the specific scope.
4. How does this patent impact regional drug development?
It restricts manufacturing and marketing of identical or similar formulations in Argentina during the patent term, affecting local R&D strategies.
5. Are there ongoing patent disputes in this area?
No publicly available information suggests active disputes involving AR107277 as of 2023; the patent remains in force.
References
[1] Argentine Patent Office. (2023). Patent database.
[2] World Intellectual Property Organization. (2023). Patent landscape reports.
[3] globalpharmapatents.com. (2023). International patent filings—therapeutic areas.
[4] TRIPS Agreement. (1994). WTO.
